University of Washington spinout AltPep will use the money to advance work on its lead asset that targets Alzheimer’s disease.

AltPep, a US-based misfolded protein treatment and diagnostics spinout of University of Washington (UW), has closed a $23.1m series A round led by Matrix Capital Management. Alexandria Venture Investments, the strategic investment division of life sciences real estate investment trust Alexandria Real Estate Equities, also backed the round. Founded in 2018, AltPep is working on…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.